Octodon degus: A strong attractor for alzheimer research

Basic and Clinical Neuroscience

Volumn 4, Issue 1, 2013, Pages 91-96

  Castro Fuentes, Rafael ^a   Socas Pérez, Rosario ^b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Department of Cognitive Psychology   (Spain)

Author keywords

Aging; Alzheimers disease; Animal model; Octodon degus

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; MELATONIN; PRESENILIN 1; PRESENILIN 2;

AGING; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CIRCADIAN RHYTHM; DISEASE MARKER; DISEASE MODEL; GENE MUTATION; GENETIC HETEROGENEITY; MEDICAL RESEARCH; NERVE DEGENERATION; NONHUMAN; OCTODON; OCTODON DEGUS; PRACTICE GUIDELINE; PROTEIN FUNCTION; PUBLICATION; RISK FACTOR; THEORETICAL STUDY; TRANSGENIC ANIMAL; VASCULAR AMYLOIDOSIS;

EID: 84875002895     PISSN: 2008126X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ardiles, A.O., Tapia-Rojas, C.C., Mandal, M., Alexandre, F., Kirkwood, A., and Inestrosa, N.C., et al. (2012). Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease. Proc Natl Acad Sci U S A, 109(34), 13835-13840.
2. Bedrosian, T.A., and Nelson, R.J. (2012). Pro: Alzheimer's disease and circadian dysfunction: chicken or egg? Alzheimers Res Ther, 4(4), 25-31.
3. Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O. and van der Kolk N., et al. (2004). Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol, 165(4), 1289-1300.
4. Cheng, G., Huang, C., Deng, H., and Wang, H. (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J, 42(5), 484-491.
5. Cheng I.H., Palop J.J., Esposito L.A., Bien-Ly N., Yan F. and Mucke L. (2004). Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med, 10(11), 1190-1192.
6. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P. and Pearson J. (2001). Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem, 276(24), 21562-21570.
7. Colonnello, V., Iacobucci, P., Fuchs, T., Newberry, R.C., and Panksepp, J. (2011). Octodon degus. A useful animal model for social-affective neuroscience research: basic description of separation distress, social attachments and play. Neurosci Biobehav Rev, 35(9), 1854-1863.
8. Davis J., Xu F., Deane R., Romanov G., Previti M.L. and Zeigler K., et al. (2004). Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem, 279(19), 20296-20306.
9. Deci, S., Lemieux, S.K., Smith-Bell, C.A., Sparks, D.L., and Schreurs, B.G. (2012). Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease. J Alzheimers Dis, 29(2), 283-292.
10. Duyckaerts, C., Delatour, B., and Potier, M.C. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol, 118(1), 5-36.
11. Edwards, M.S. (2009). Nutrition and behavior of degus (Octodon degus). Vet Clin North Am Exot Anim Pract, 12(2), 237-253.
12. Galuppo, S., Bacigalupo, A., García, A., Ortiz, S., Coronado, X., and Cattan, P.E., et al. (2009). Predominance of Trypanosoma cruzi genotypes in two reservoirs infected by sylvatic Triatoma infestans of an endemic area of Chile. Acta Trop, 111(1), 90-93.
13. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C.,et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature, 373(6514), 523-527
14. Guénette, S.Y., and Tanzi, R.E. (1999). Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol. Aging, 20(2), 201-211.
15. Hardy, J., and Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297(5580), 353-356.
16. Helzner, E.P., Luchsinger, J.A., Scarmeas, N., Cosentino, S., Brickman, A.M., and Glymour, M.M., et al. (2009). Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol, 66(3), 343-348.
17. Herzig M.C., Winkler D.T., Burgermeister P., Pfeifer M., Kohler E. and Schmidt S.D., et al. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci, 7(9), 954-960
18. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S. and Jantzen P., et al. (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med, 4(1), 97-100.
19. Homan, R., Hanselman, J.C., Bak-Mueller, S., Washburn, M., Lester, P., and Jensen, H.E., et al. (2010). Atherosclerosis in Octodon degus (degu) as a model for human disease. Atherosclerosis, 212(1), 48-54.
20. Honjo, K., van Reekum, R., and Verhoeff, N.P. (2009). Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement, 5(4), 348-360.
21. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274(5284), 99-102.
22. Inestrosa, N.C., Reyes, A.E., Chacón, M.A., Cerpa, W., Villalón, A., and Montiel, J., et al. (2005). Human-like rodent amyloidbeta-peptide determines Alzheimer pathology in aged wildtype Octodon degu. Neurobiol Aging, 26(7), 1023-1028.
23. Itzhaki, R.F., and Wozniak, M.A. (2008). Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis, 13(4), 393-405.
24. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., and Weiner, M.W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol, 9(1), 119-128.
25. Knobloch M., Konietzko U., Krebs D.C. and Nitsch R.M. (2007). Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging, 28(9), 1297-1306.
26. Lee, S.J., Liu, T., Chattoraj, A., Zhang, S.L., Wang, L., and Lee, T.M., et al. (2009). Posttranscriptional regulation of pineal melatonin synthesis in Octodon degus. J Pineal Res, 47(1), 75-81.
27. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A. and Jones G., et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293(5534), 1487-1491.
28. Lord A., Kalimo H., Eckman C., Zhang X.Q., Lannfelt L. and Nilsson L.N. (2006). The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol Aging, 27(1), 67-77.
29. Lukaszewska, I., and Radulska, A. (1994). Object recognition is not impaired in old rats. Acta Neurobiol Exp (Wars), 54(2), 143-150.
30. Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., and Morris, J.C., et al. (2010). Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science, 330(6012), 1774.
31. Oakley H., Cole S.L., Logan S., Maus E., Shao P. and Craft J., et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci, 26(40), 10129-10140.
32. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E. and Kayed R., et al. (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39(3), 409-421.
33. Ortiz, V., Lozano, J.P., Rol de Lama, M.A., and Madrid, J.A. (2005). Rendimiento y deterioro cognitivo en Octodon degu, un nuevo modelo para ensayos conductuales. In: XLVII Congreso de la Sociedad Española de Geriatría y Gerontología, Málaga, Spain, June 8-11.
34. Popovic, N., Baño-Otálora, B., Rol, M.A., Caballero-Bleda, M., Madrid, J.A., and Popovic, M. (2009). Aging and time-of-day effects on anxiety in female Octodon degus. Behav. Brain Res, 200(1), 117-121.
35. Povova, J., Ambroz, P., Bar, M., Pavukova, V., Sery, O., and Tomaskova, H., et al. (2012). Epidemiological of and risk factors for Alzheimer's disease: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 156(2), 108-114.
36. Robinson, S.R., Dobson, C., and Lyons, J. (2004). Challenges and directions for the pathogen hypothesis of Alzheimer's disease. Neurobiol Aging, 25(5), 629-637.
37. Rönnbäck A., Zhu S., Dillner K., Aoki M., Lilius L. and Näslund J., et al. (2011). Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model. Neurobiol Aging, 32(2), 280-292.
38. Rosenzweig, E.S., and Barnes, C.A. (2003). Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol, 69(3), 143-179.
39. Schaeffer E.L., Figueiro M. and Gattaz W.F. (2011). Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo), 66(Suppl 1), 45-54.
40. Selkoe, D.J. (2011). Resolving controversies on the path to Alzheimer's therapeutics. Nat Med, 17(9), 1060-1065.
41. Selkoe, D.J., and Wolfe, M.S. (2007). Presenilin: running with scissors in the membrane. Cell, 131(2), 215-221.
42. Sims-Robinson, C., Kim, B., Rosko, A., and Feldman, E.L. (2010). How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol, 6(10), 551-559.
43. Sleegers, K., Lambert, J.C., Bertram, L., Cruts, M., Amouyel, P., and Van Broeckhoven, C. (2010). The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet, 26(2), 84-93.
44. Sparks, D.L. (2008). The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot. J Alzheimers Dis, 15(4), 641-656.
45. Spear, G.S., Caple, M.V., and Sutherland, L.R. (1984). The pancreas in the degu. Exp Mol Pathol, 40(3), 295-310.
46. Srinivasan, V., Pandi-Perumal, S.R., Maestroni, G.J., Esquifino, A.I., Hardeland, R., and Cardinali, D.P. (2005). Role of melatonin in neurodegenerative diseases. Neurotox Res, 7(4), 293-318.
47. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C. and Rothacher S., et al. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA, 94(24),13287-13292.
48. Tan, D.X., Manchester, L.C., Reiter, R.J., Qi, W.B., Karbownik, M., and Calvo, J.R. (2000). Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept, 9(3-4), 137-159.
49. Tannock, L.R., and King, V.L. (2010). Animal models of atherosclerosis: more than mice. Atherosclerosis, 212(1), 32-33.
50. Tanzi, R.E., and Bertram, L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell, 120(4), 545-555.
51. Tanzi, R.E., Moir, R.D., and Wagner, S.L. (2004). Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron, 43(5), 605-608.
52. Van Groen, T., Kadish, I., Popović, N., Popović, M., Caballero-Bleda, M., and Baño-Otálora, B., et al. (2011). Vivanco P, Rol MÁ, Madrid JA. Age-related brain pathology in Octodon degu: blood vessel, white matter and Alzheimer-like pathology. Neurobiol Aging, 32(9), 1651-1661.
53. Vivanco, P., Ortiz, V., Rol, M.A., and Madrid, J.A. (2007). Looking for the keys to diurnality downstream from the circadian clock: role of melatonin in a dual-phasing rodent, Octodon degus. J Pineal Res, 42(3), 280-290.
54. Willig, F., Palacios, A., Monmaur, P., M'Harzi, M., Laurent, J., and Delacour, J. (1987). Short-term memory, exploration and locomotor activity in aged rats. Neurobiol Aging, 8(5), 393-402.
55. Wirths O., Multhaup G., Czech C., Feldmann N., Blanchard V. and Tremp G., et al. (2002). Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol, 12(3), 275-286.
56. Zlokovic, B.V. (2008).The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 57(2), 178- 201.